2025 Performance Overview: Lithium Americas Corp (LAC) Spin-Off Sets the Stage: Lithium Americas underwent a major transformation in late 2023, splitting into two independent companies. As of October 2023, Lithium Americas “NewCo” (NYSE: LAC) took over the U.S.-based assets (primarily the Thacker Pass project in Nevada), while Lithium Argentina (NYSE: LAAC) holds the Argentine operations. This separation, completed on Oct 3, 2023, sharpened LAC’s focus as a pure-play North American lithium developer. Investors received shares in both new entities, and trading of the new LAC began around $12.40 per share in October 2023. Stock Price Volatility: Post-spinoff, LAC’s stock saw
Key Facts & Figures 📊 The Metals Company Overview: Undersea Minerals for the EV Boom The Metals Company (“TMC”) is a deep-sea minerals exploration firm on a mission to harvest polymetallic nodules – often called “a battery in a rock” – from the ocean floor metals.co investors.metals.co. These potato-sized nodules are extraordinarily rich in critical battery metals: nickel, cobalt, copper, and manganese. TMC’s business model is to collect nodules from the Clarion-Clipperton Zone (CCZ) of the Pacific Ocean (in international waters between Hawaii and Mexico) and process them into high-grade metals needed for electric vehicle (EV) batteries, renewable energy technology,
Southern Copper Corporation Overview and Market Outlook as of September 24, 2025 SCCO Stock Performance in Late September 2025 Southern Copper’s stock has been on a tear in recent weeks, climaxing with a sharp rally around September 24, 2025. On that day, SCCO surged roughly 8–9%, hitting a new 52-week high of about $117–$121 per share ca.investing.com ainvest.com. This jump was the stock’s largest single-day gain in over a year ainvest.com. The rally coincided with a spike in copper prices, underscoring Southern Copper’s sensitivity to the commodity. Year-to-date, SCCO is up roughly 27%, reflecting robust investor confidence and far outpacing
Pfizer shares rose 2.8% to $27.22 Friday after the FDA granted priority review for a Hympavzi label expansion, with a decision expected in Q2 2026. Trading volume reached 50.7 million shares. The TrumpRx.gov drug-discount rollout put renewed focus on pricing, with over 30 Pfizer drugs listed at launch.
Bitfarms shares jumped 25.2% to $2.14 Friday after the company announced plans to move its legal home to the U.S. and rebrand as Keel Infrastructure, pending a March 20 shareholder vote. The company also said it will repay its $100 million Macquarie debt facility and reported $698 million in net liquidity.
CoreWeave shares surged 20.5% to $89.95 Friday, capping a volatile week for AI stocks. The company launched its ARENA lab and a new ad campaign, and set Feb. 26 for its earnings release. SVP Chen Goldberg sold nearly 18,000 shares for tax withholding. A securities class action lawsuit was filed covering trades from March 28 to Dec. 15, 2025.
Arista Networks shares jumped 6.85% to $137.49 Friday, breaking a two-day slide on volume of about 9 million shares, above average. The move came ahead of Arista’s earnings set for Feb. 12 and U.S. CPI data on Feb. 13. Options pricing signals traders expect volatility around the results. The Dow closed above 50,000 for the first time.